FDA Inspection 1111913 — Fareez Mohamed, MD
The FDA completed an inspection of Fareez Mohamed, MD on October 31, 2019 in Basingstoke. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 31, 2019
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Basingstoke (United Kingdom)
Additional Details
Clinical Investigator (CI)